Chitosan‐based nanoparticles loaded with anti‐HTT siRNA was intranasally administrated to a transgenic YAC128 mouse model of HD, which resulted in a decrease of HTT mRNA expression at over 50% [157]. The gene discussed is HTT; the disease is Huntington disease.